EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials

Marco Ratta iD, Gaëlle Saint-Hilary, Valentine Barboux, Mauro Gasparini iD, Donia Skanji, Pavel Mozgunov

Statistics in Medicine · 2026

DOI: 10.1002/sim.70361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2026. Verfasst von Marco Ratta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematical Sciences, Polytechnic University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Drug Approval, Clinical Trials as Topic. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Institut de Recherches Servier, Department of Health Care Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The urgency of delivering novel, effective treatments against life‐threatening diseases has brought various health authorities to allow for Accelerated Approvals (AAs). AA is the “fast track” program where promising treatments are evaluated based on surrogate (short term) endpoints likely to predict clinical benefit. This allows treatments to get an early approval, subject to providing further evidence of efficacy, for example, on the primary (long term) endpoint. Despite this procedure being quite consolidated, a number of conditionally approved treatments do not obtain full approval (FA), mainly due to lack of correlation between surrogate and primary endpoint. This implies a need to improve the criteria for controlling the risk of AAs for noneffective treatments, while maximizing the chance of AAs for effective ones. We first propose a novel adaptive group sequential design that includes an early dual‐criterion “Accelerated Approval” interim analysis, where efficacy on a surrogate endpoint is tested jointly with a predictive metric based on the primary endpoint. Secondarily, we explore how the predictive criterion may be strengthened by historical information borrowing, in particular using: (i) historical control data on the primary endpoint, and (ii) the estimated historical relationship between the surrogate and the primary endpoints. We propose various metrics to characterize the risk of correct and incorrect early AAs and demonstrate how the proposed design allows explicit control of these risks, with particular attention to the family‐wise error rate (FWER). The methodology is then evaluated through a simulation study motivated by a Phase‐III trial in metastatic colorectal cancer (mCRC).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ApprovalClinical Trials as TopicHumansEndpoint DeterminationColorectal NeoplasmsComputer SimulationBiomarkersResearch DesignModels, Statistical

Stichwörter der Autor:innen

accelerated approvalgroup sequential designhistorical dataprobability of successsurrogate endpoint

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Mathematical Sciences, Polytechnic University of Turin, Turin, Italy.
  • Department of Statistical Methodology, Saryga, Tournus, France.
  • Servier National Research Institute (IRIS), Servier, Gif-sur-Yvette, France.
  • MRC Biostatistics Unit, Cambridge University, Cambridge, UK.

ORCID-Profile: Marco Ratta, Mauro Gasparini

Förderung

  • National Institute for Health and Care Research
  • Institut de Recherches Servier
  • Department of Health Care Services

Zitieren

APA

Ratta, M., Saint-Hilary, G., Barboux, V., Gasparini, M., Skanji, D., & Mozgunov, P. (2026). Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials. Statistics in Medicine. https://doi.org/10.1002/sim.70361

Vancouver

Ratta M, Saint-Hilary G, Barboux V, Gasparini M, Skanji D, Mozgunov P. Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials. Statistics in Medicine. 2026. doi:10.1002/sim.70361

BibTeX
@article{Ratta2026,
  author = {Ratta, Marco and Saint-Hilary, Gaëlle and Barboux, Valentine and Gasparini, Mauro and Skanji, Donia and Mozgunov, Pavel},
  title = {Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials},
  journal = {Statistics in Medicine},
  year = {2026},
  doi = {10.1002/sim.70361}
}
Kostenlos starten →